Table 1 Demographic and clinical characteristics of the participants at baseline
FT (N = 20) | RE (N = 21) | |
|---|---|---|
Age—(years) mean (SD) | 52.4 (10.0) | 51.0 (11.6) |
Gender (%) | ||
Male | 10 (50%) | 9 (46%) |
Female | 10 (50%) | 11 (54%) |
Peripheral manifestation (%) | 4 (19.0%) | 17 (81%) |
Axial + peripheral manifestation (%) | 1 (5.0%) | 4 (19%) |
Disease duration—(years) mean (SD) | 12.8 (9.9) | 16.0 (10.8) |
Associated diseases (%) | ||
Systemic arterial hypertension | 15 (75%) | 10 (48%) |
Diabetes Mellitus | 5 (25%) | 11 (52%) |
Medications (%) | ||
Methotrexate | 16 (80%) | 17 (80%) |
Acetylsalicylicacid | 3 (15%) | 7 (33%) |
Folicacid | 4 (20%) | 5 (23%) |
Enalapril | 2 (10%) | 7 (33%) |
Hydrochlorothiazide | 3 (15%) | 4 (19%) |
Inflixmabe | 3 (15%) | 5 (23%) |
Cyclosporine | 4 (20%) | 3 (14%) |
Smoking n (%) | 0 (%) | 0 (%) |